List of Tables
Table 1. Blood Cancer Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Blood Cancer Therapeutics Market Trends
Table 3. Blood Cancer Therapeutics Market Drivers
Table 4. Blood Cancer Therapeutics Market Challenges
Table 5. Blood Cancer Therapeutics Market Restraints
Table 6. Global Blood Cancer Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Blood Cancer Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Blood Cancer Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Blood Cancer Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Blood Cancer Therapeutics Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Blood Cancer Therapeutics Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Blood Cancer Therapeutics Revenue Share by Player, 2017-2022
Table 13. Global Blood Cancer Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Blood Cancer Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Cancer Therapeutics as of 2021)
Table 15. Top Players of Blood Cancer Therapeutics in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Blood Cancer Therapeutics Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Blood Cancer Therapeutics Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Blood Cancer Therapeutics Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Blood Cancer Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Blood Cancer Therapeutics Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Blood Cancer Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Blood Cancer Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Blood Cancer Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Blood Cancer Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Blood Cancer Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Blood Cancer Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Blood Cancer Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Blood Cancer Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. AbbVie Company Details
Table 31. AbbVie Business Overview
Table 32. AbbVie Blood Cancer Therapeutics Product
Table 33. AbbVie Revenue in Blood Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 34. AbbVie Recent Development
Table 35. AstraZeneca Company Details
Table 36. AstraZeneca Business Overview
Table 37. AstraZeneca Blood Cancer Therapeutics Product
Table 38. AstraZeneca Revenue in Blood Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 39. AstraZeneca Recent Development
Table 40. Bristol-Myers Squibb Company Details
Table 41. Bristol-Myers Squibb Business Overview
Table 42. Bristol-Myers Squibb Blood Cancer Therapeutics Product
Table 43. Bristol-Myers Squibb Revenue in Blood Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 44. Bristol-Myers Squibb Recent Development
Table 45. GlaxoSmithKline Company Details
Table 46. GlaxoSmithKline Business Overview
Table 47. GlaxoSmithKline Blood Cancer Therapeutics Product
Table 48. GlaxoSmithKline Revenue in Blood Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 49. GlaxoSmithKline Recent Development
Table 50. Roche Company Details
Table 51. Roche Business Overview
Table 52. Roche Blood Cancer Therapeutics Product
Table 53. Roche Revenue in Blood Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 54. Roche Recent Development
Table 55. Novartis Company Details
Table 56. Novartis Business Overview
Table 57. Novartis Blood Cancer Therapeutics Product
Table 58. Novartis Revenue in Blood Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 59. Novartis Recent Development
Table 60. Boehringer Ingelheim Company Details
Table 61. Boehringer Ingelheim Business Overview
Table 62. Boehringer Ingelheim Blood Cancer Therapeutics Product
Table 63. Boehringer Ingelheim Revenue in Blood Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 64. Boehringer Ingelheim Recent Development
Table 65. Pfizer Company Details
Table 66. Pfizer Business Overview
Table 67. Pfizer Blood Cancer Therapeutics Product
Table 68. Pfizer Revenue in Blood Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 69. Pfizer Recent Development
Table 70. Sanofi Company Details
Table 71. Sanofi Business Overview
Table 72. Sanofi Blood Cancer Therapeutics Product
Table 73. Sanofi Revenue in Blood Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 74. Sanofi Recent Development
Table 75. Research Programs/Design for This Report
Table 76. Key Data Information from Secondary Sources
Table 77. Key Data Information from Primary Sources
List of Figures
Figure 1. Blood Cancer Therapeutics Product Picture
Figure 2. Global Blood Cancer Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Blood Cancer Therapeutics Market Size 2017-2028 (US$ Million)
Figure 4. United States Blood Cancer Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Blood Cancer Therapeutics Market Size 2017-2028 (US$ Million)
Figure 6. United States Blood Cancer Therapeutics Market Share in Global 2017-2028
Figure 7. Blood Cancer Therapeutics Report Years Considered
Figure 8. Product Picture of Chronic Myeloid Leukemia (CML)
Figure 9. Product Picture of Acute Lymphocytic Leukemia (ALL)
Figure 10. Product Picture of Chronic Lymphocytic Leukemia (CLL)
Figure 11. Product Picture of Acute Myeloid Leukemia (AML)
Figure 12. Global Blood Cancer Therapeutics Market Share by Type in 2022 & 2028
Figure 13. Global Blood Cancer Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 14. Global Blood Cancer Therapeutics Market Share by Type (2017-2028)
Figure 15. United States Blood Cancer Therapeutics Market Share by Type in 2022 & 2028
Figure 16. United States Blood Cancer Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 17. United States Blood Cancer Therapeutics Market Share by Type (2017-2028)
Figure 18. Product Picture of Cancer Research Centers
Figure 19. Product Picture of Cancer Hospital
Figure 20. Product Picture of Surgical Centers
Figure 21. Product Picture of Clinics
Figure 22. Global Blood Cancer Therapeutics Market Share by Application in 2022 & 2028
Figure 23. Global Blood Cancer Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 24. Global Blood Cancer Therapeutics Market Share by Application (2017-2028)
Figure 25. United States Blood Cancer Therapeutics Market Share by Application in 2022 & 2028
Figure 26. United States Blood Cancer Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 27. United States Blood Cancer Therapeutics Market Share by Application (2017-2028)
Figure 28. North America Blood Cancer Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 29. U.S. Blood Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. Canada Blood Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. Europe Blood Cancer Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 32. Germany Blood Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. France Blood Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. U.K. Blood Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Italy Blood Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Russia Blood Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Asia-Pacific Blood Cancer Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 38. China Blood Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Japan Blood Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. South Korea Blood Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. India Blood Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Australia Blood Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Taiwan Blood Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Indonesia Blood Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Thailand Blood Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Malaysia Blood Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Philippines Blood Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Latin America Blood Cancer Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 49. Mexico Blood Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Brazil Blood Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Argentina Blood Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Blood Cancer Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 53. Turkey Blood Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Blood Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. U.A.E Blood Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 56. AbbVie Revenue Growth Rate in Blood Cancer Therapeutics Business (2017-2022)
Figure 57. AstraZeneca Revenue Growth Rate in Blood Cancer Therapeutics Business (2017-2022)
Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Blood Cancer Therapeutics Business (2017-2022)
Figure 59. GlaxoSmithKline Revenue Growth Rate in Blood Cancer Therapeutics Business (2017-2022)
Figure 60. Roche Revenue Growth Rate in Blood Cancer Therapeutics Business (2017-2022)
Figure 61. Novartis Revenue Growth Rate in Blood Cancer Therapeutics Business (2017-2022)
Figure 62. Boehringer Ingelheim Revenue Growth Rate in Blood Cancer Therapeutics Business (2017-2022)
Figure 63. Pfizer Revenue Growth Rate in Blood Cancer Therapeutics Business (2017-2022)
Figure 64. Sanofi Revenue Growth Rate in Blood Cancer Therapeutics Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed